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Cynara scolymus L. (artichoke) is today widely cultivated all over the world for its large fleshy 
immature inflorescences and known since ancient times as a tasty plant that can be used in 
soups, stews and salads, being perceived as a nutritious and healthy vegetable due to its 
antioxidant and hepatoprotective effects [1]. Silybum marianum (L.) Gaertn (milk thistle) is an 
hercaceous plant with reported effects against hepatotoxicity and acute and chronic liver 
diseases, due to its main pharmacological active ingredient si lymarin (standard mixture of 
flavonoligans) that also has antioxidant properties [2,3]. Thus, artichoke and milk thistle are two 
plants widely used regarding hepatoprotective effects but to the best of our knowledge no anti-
hepatocellular carcinoma activity has been studied, particularly in the most consumed forms: 
infusions and dietary supplements. In the present work, antioxidant properties (reducing power, 
radical scavenging activity and lipid peroxidation inhibition), anti-hepatocellular carcinoma activity 
(HepG2 tumour cell lines) and hepatotoxicity (non-tumour liver primary culture PLP2) of infusions 
and dietary supplements of the mentioned plants were evaluated and compared. Both plants 
revealed antioxidant properties with EC50 values lower than the daily recommended dose. The 
infusions of milk thistle and artichoke revealed, in general, sim ilar contents in phenolics and 
antioxidant activity. Artichoke infusion also presented anti-hepatocellular carcinoma activity (GI50 = 
52 1-lg/ml) but with some toxicity for normal liver primary cells at concentrations higher than Gl50 = 
72 11g/ml. The studied bioactive properties (antioxidant and antitumour) were positively correlated 
with phenolics and flavonoids content.Regarding dietary supplements, the bioactive compounds 
amount and antioxidant activity of milk thistle was higher than artichoke's. These samples neither 
revealed anti-hepatocelullar carcinoma activity, nor toxicity for normal liver cells. 
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